Research map: PYY 3-36 potentiates Semaglutide‑mediated mitochondrial modulation in MASLD

Back to the article

Papers in this map

  1. PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT · Oliver H. Lowry · 1951 · 318893 citations · Cited by this paper
  2. Expression of Concern for Choi et al., volume 297, 2009, p. E1304–E1312 · 2026 · Related
  3. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 · Michael I. Love · 2014 · 104531 citations · Cited by this paper
  4. Bridging the gap: Multi-omic Insights into Exercise Responses in Post-Menopausal Women · 2026 · Related
  5. STAR: ultrafast universal RNA-seq aligner · Alexander Yu. Dobin · 2012 · 58150 citations · Cited by this paper
  6. Publisher’s note · 2026 · Related
  7. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features · Yang Liao · 2013 · 30442 citations · Cited by this paper
  8. Gut microbiota transplantation from young adult mice fails to restore low bone and muscle mass in old mice · 2026 · Related
  9. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository · Ron Edgar · 2002 · 14124 citations · Cited by this paper
  10. Impact of nesting materials on energy balance in male C57BL/6J mice exposed to different ambient temperatures · 2026 · Related
  11. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data · Tianzhi Wu · 2021 · 13207 citations · Cited by this paper
  12. Acute overfeeding impairs meal-stimulated adipose tissue microvascular blood flow in healthy adults independent of changes in adiposity · 2026 · Related
  13. Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity · Jeffrey D. Browning · 2004 · 3695 citations · Cited by this paper
  14. Obesity-related circulating endothelial extracellular vesicles negatively affect cerebral microvascular cell function · 2026 · Related
  15. Pathview: an R/Bioconductor package for pathway-based data integration and visualization · Weijun Luo · 2013 · 2488 citations · Cited by this paper
  16. Pioglitazone increases adiponectin and attenuates the appearance of diet-induced insulin resistance in high-fat-fed beagles · 2026 · Related
  17. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study · Matthew James Armstrong · 2015 · 2191 citations · Cited by this paper
  18. Bone marrow adipose tissue mass and dipeptidyl peptidase-4 link aging and metabolic health to biomarkers of bone turnover · 2026 · Related
  19. Organelle isolation: functional mitochondria from mouse liver, muscle and cultured filroblasts · Christian Frezza · 2007 · 1215 citations · Cited by this paper
  20. Alterations in glucocorticoid homeostasis following sleeve gastrectomy in male mice · 2026 · Related
  21. Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in Steatohepatitis · Chrysi C. Koliaki · 2015 · 1054 citations · Cited by this paper
  22. Triglyceride Metabolism in the Liver · Michele Alves‐Bezerra · 2017 · 1033 citations · Cited by this paper
  23. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease · Yuki Kawano · 2013 · 980 citations · Cited by this paper
  24. Changing epidemiology, global trends and implications for outcomes of NAFLD · Vincent Wai‐Sun Wong · 2023 · 750 citations · Cited by this paper
  25. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis · Alessandro Mantovani · 2021 · 671 citations · Cited by this paper
  26. Establishment of a General NAFLD Scoring System for Rodent Models and Comparison to Human Liver Pathology · Wen Liang · 2014 · 618 citations · Cited by this paper
  27. Role of Insulin Resistance in MAFLD · Yoshitaka Sakurai · 2021 · 446 citations · Cited by this paper
  28. PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis · Sven Francque · 2015 · 363 citations · Cited by this paper
  29. Current treatment of non‐alcoholic fatty liver disease · Rafael Paternostro · 2022 · 307 citations · Cited by this paper
  30. Updated mechanisms of MASLD pathogenesis · Yuxuan Li · 2024 · 295 citations · Cited by this paper
  31. High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial functionin vivo · Sudheer Kumar Mantena · 2008 · 265 citations · Cited by this paper
  32. Non-Alcoholic Fatty Liver Disease · Atilla Engin · 2017 · 252 citations · Cited by this paper
  33. Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non‐alcoholic fatty liver disease assessed by magnetic resonance imaging · Anne Flint · 2021 · 222 citations · Cited by this paper
  34. Incretins (GLP-1 receptor agonists and dual/triple agonists) and the liver · Philip Noel Newsome · 2023 · 204 citations · Cited by this paper
  35. Effects of PYY3–36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men · Julie Berg Schmidt · 2014 · 145 citations · Cited by this paper
  36. Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD) · Majid Mufaqam Syed‐Abdul · 2023 · 138 citations · Cited by this paper
  37. Nitric oxide and energy metabolism in mammals · Zhaolai Dai · 2013 · 125 citations · Cited by this paper
  38. The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease · Ilias D. Vachliotis · 2023 · 121 citations · Cited by this paper
  39. Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease · Maria E. Moreno‐Fernandez · 2018 · 103 citations · Cited by this paper

Source: OpenAlex (CC0)